Upcoming Allied Market Research
Recombinant Factor C Assay Market

Recombinant Factor C Assay Market

Size, Share, Competitive Landscape and Trend Analysis Report by  Brand (PyroGene  ,  PyroGene Bulk, PyroGene rFC), by EndoNext (EndoZyme II  , EndoZyme IIGO, EndoLisa) and by End User (Pharmaceutical Companies    ,  Biotechnology Companies, Medical Device Companies, Contract Research Organizations, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A13438
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


Recombinant factor C is a non-animal-derived reagent used to detect endotoxins in various pharmaceutical products. Furthermore, recombinant factor C assay test is a new age alternative test against limulus amebocyte lysate employed toward endotoxin testing of products for pyrogen. Decrease in the population of horseshoe crab around the globe especially in parts of Asia is a major factor for shift toward recombinant factor C assay. The reagent is activated through endotoxin binding and subsequent substrate cleaving, resulting in release of a fluorogenic compound. The test employs a single step procedure vis-à-vis LAL test. In layman terms, the test does not make use of horseshoe crab’s endotoxin protein as compared to LAL test. One of the major reasons why recombinant factor C assay is at the fulcrum is the dire global demand for search and adoption of an animal-free endotoxin testing procedure.

COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the recombinant factor C assay market.

Top Impacting Factors

  • PyroGene is anticipated to gain market traction for being a single-step enzymatic process as compared to other multiple step procedures. This is likely to increase overall market share of recombinant factor C assay market.
  • Noval rFC methods are likely to gain huge market potential as being a sustainable solution for endodoxin testing. The method is known to provide higher accuracy and specificity vis-à-vis Limutus Amebocyte Lysate (LAL), which again is a growth factor impacting recombinant factor C assay market.
  • Overall rise in the need for endotoxin detection tests around the globe combined with the need of coming up with more accurate, timely, and efficient tests is a factor driving growth in the market.
  • However, adverse decline in the horseshoe crab and fear of their extinction act as the key restraints of the overall growth of recombinant factor C assay market.

Key Market Trends

United States Pharmacopeia (USP) has reinforced its commitment for introduction and wide spread distribution of recombinant factor C in an attempt to discover new age tests for detection of bacterial endotoxins and other injectable therapeutics.

Recently, Lonza, a global pharmaceutical player announced a new recombinant factor C assay against endotoxin testing of galcanezumab. It was Lonzo who had earlier launched PyroGene in 2003 as well. The development proves that (rFc) is as accurate and specific as LAL-based technique in helping to secure the supply of natural resources.

North America is anticipated to retain its position as the market leader, owing to increase in incorporation on rFC’s in United States pharmaceutical dynamics, strong presence of market players, and robust investments in the field of recombinant technology.

Among the brands, PyroGene is anticipated to account for largest share in global recombinant factor C assay market, as it is the foremost successful assay deployed against LAL tests.

India and China are witnessing market gains, owing to increase in private sector investments into biotechnology field.

Key Benefits of the Report

  • This study presents the analytical depiction of the recombinant factor C assay industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the recombinant factor C assay market share.
  • The current market is quantitatively analyzed to highlight recombinant factor C assay market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the recombinant factor C assay market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Recombinant Factor C Assay Report

  • Which are the leading players active in the recombinant factor C assay market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the recombinant factor C assay market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is recombinant factor C assay?
  • What is the recombinant factor C assay market prediction in the future?
  • What are the current trends and predicted trends?

Recombinant Factor C Assay Market Report Highlights

Aspects Details
By  Brand
  • PyroGene  
  •  PyroGene Bulk
  • PyroGene rFC
By EndoNext
  • EndoZyme II  
  • EndoZyme IIGO
  • EndoLisa
By End User
  • Pharmaceutical Companies    
  •  Biotechnology Companies
  • Medical Device Companies
  • Contract Research Organizations
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Sanofi Pasteur Limited, Genentech Inc, Eli Lilly, Thermofisher Scientific Inc, Glaxosmith Kline Plc., Merck KGaA, Hyglos GmbH, Pfizer, Novartis AG, Lonza Group

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Recombinant Factor C Assay Market

Start reading.
This Report and over 71,229+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save the time of readers